Page last updated: 2024-10-23

azathioprine and Dacryoadenitis

azathioprine has been researched along with Dacryoadenitis in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hibino, M1
Kondo, T1
Andrew, NH1
Kearney, D1
Sladden, N1
McKelvie, P1
Wu, A1
Sun, MT1
McNab, A1
Selva, D1

Other Studies

2 other studies available for azathioprine and Dacryoadenitis

ArticleYear
Dacryoadenitis with Ptosis and Diplopia as the Initial Presentation of Granulomatosis with Polyangiitis.
    Internal medicine (Tokyo, Japan), 2017, Oct-01, Volume: 56, Issue:19

    Topics: Adrenal Cortex Hormones; Aged; Asian People; Azathioprine; Dacryocystitis; Diplopia; Female; Granulo

2017
Idiopathic Dacryoadenitis: Clinical Features, Histopathology, and Treatment Outcomes.
    American journal of ophthalmology, 2016, Volume: 163

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Child; Dacryocystitis; Drug Resist

2016